Eton PharmaceuticalsvsMerck & Company

ETON and MRK stock compared: price, dividend, valuation and results, from SEC filings.

ETON

Eton Pharmaceuticals, Inc.

$61.99

Value $1.8B

-2.61%
ETON's page

MRK

Merck & Company, Inc.

$137.78

Value $341B

-3.90%
MRK's page

Eton Pharmaceuticals (ETON) has a market value of $1.8B and Merck & Company (MRK) $341B. Over the last year, with dividends, ETON moved +259.2% and MRK +52.7%. Dividend yield: ETON none, MRK 2.47%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ETON$1.8B

    MRK$341B

    MRK is 191 times ETON

  • Revenue, 12 months

    ETON$141M

    MRK$67.4B

    MRK is 478 times ETON

  • Net income, 12 months

    ETON$50M

    MRK$2.5B

    MRK is 49 times ETON

  • Operating margin

    ETON28.8%

    MRK–

  • ROIC

    ETON45.1%

    MRK3.9%

    41.2 points apart

  • P/E

    ETON–

    MRK138.9

  • Dividend yield

    ETON0.0%

    MRK2.5%

    2.5 points apart

  • 5-year return

    ETON+1,238.9%

    MRK+94.3%

    1,144.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ETON+1,238.9%

MRK+94.3%

0500100020222023202420252026
Returns by period
PeriodETONWith dividendsMRKWith dividends
1 year since November 17, 2025+259.2%Price +259.2%+52.7%Price +48.4%
3 years since November 17, 2023+1,651.1%+159.7% a yearPrice +1,651.1%+48.4%+14.1% a yearPrice +35.4%
5 years since November 17, 2021+1,238.9%+68.0% a yearPrice +1,238.9%+94.3%+14.2% a yearPrice +66.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ETONEton PharmaceuticalsMRKMerck & Company

Valuation

ETONMRK
Valuation
Price$61.99$137.78
Market value$1.8B$341B
Enterprise value (EV)–$385B
P/E–138.9
P/E, 5-year median–14.8
P/B20.67.6
EV/EBIT–80.8
Free cash flow yield2.1%4.3%

Results and growth

ETONMRK
Results and growth
Revenue, 12 months$141M$67.4B
Net income, 12 months$50M$2.5B
Free cash flow, 12 months$38M$14.7B
Earnings per share, 12 months$1.77$0.98
Revenue growth, year on year104.9%1.3%
Revenue growth a year, past+359.6%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

ETONMRK
Margins and returns on capital
Gross margin69.2%71.8%
Operating margin28.8%–
Net margin35.4%3.6%
ROIC45.1%3.9%
ROE116.8%5.2%

Balance sheet

ETONMRK
Balance sheet
Cash$56M$9.7B
Total debt–$53.8B
Net debt / EBITDA–5.7
Interest cover8.9×2.4×

Dividends and buybacks

ETONMRK
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.5%
Shareholder yield–4.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ETON or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Eton Pharmaceuticals or Merck & Company?

By market value, Merck & Company ($341B) is about 190.5 times Eton Pharmaceuticals ($1.8B), at today's prices.

How did ETON and MRK stock do over the last 5 years?

Since November 17, 2021, ETON's price moved +1,238.9% and MRK's +66.8%. With dividends: ETON +1,238.9% (+68.0% a year), MRK +94.3% (+14.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, ETON or MRK?

The dividend yield at today's price is none for Eton Pharmaceuticals and 2.47% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, Eton Pharmaceuticals or Merck & Company?

Over the last twelve months, the net margin was 35.4% for Eton Pharmaceuticals and 3.6% for Merck & Company, and the operating margin 28.8% and –. Revenue was $141M and $67.4B.

Which is the better investment, Eton Pharmaceuticals or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.